Drug Interactions
1,007 results
614 - 713
Resistance testing: phenotype
Metformin
Taenia solium- Minocycline
- Tetracycline
- Bromocriptine
- Complementary and Alternative Medicine: Herbals
- Sulfadiazine
- Caspofungin acetate
- Neomycin
- Lefamulin
- Kanamycin
- Methadone
Gabapentin- Quinine
- Yellow fever vaccine
- Mefloquine
- Orlistat
- Fusarium
- Simeprevir
- Simeprevir
- Ritonavir
- Ritonavir
- Lenacapavir
- Nirmatrelvir/Ritonavir
- Nirmatrelvir/Ritonavir
- Indinavir
- Indinavir
- Tricyclic antidepressants
- Tasimelteon
- Tobramycin
- Amikacin
- Cryptococcus
- Antipsychotics
- Valganciclovir
- Valganciclovir
- Posaconazole
- Posaconazole
- Nelfinavir
- Nelfinavir
- Tuberculosis, Active
- Antiretroviral Therapy: Treatment-Experienced Patients
- Telaprevir
- Telaprevir
- First-Generation Neuroleptics
- Antimicrobials with Special Precautions in Diabetes
- Rifabutin
- Rifabutin
- Candidiasis, esophageal
- Gentamicin
- Ofloxacin
- Chloramphenicol
- Delavirdine
- Other Antidepressants
- Nefazodone
- Fluoxetine
- Medications Template
- Histoplasmosis
- Saquinavir
- Saquinavir
- Omega-3-fatty acid (Fish oil)
- Amphotericin B liposomal
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Moxifloxacin
- Ketoconazole
- Metoclopramide
- Sparfloxacin
- Ketoconazole
- Moxifloxacin
- Statins and Combination Pills
- Narcotic Analgesics
- Virologic failure: When to modify therapy
- Mycobacterium avium-complex (MAC, MAI, non-HIV)
- Proteus species
- Bartonella Species
- Escherichia coli
- Coccidioidomycosis
- Raltegravir
- Antidepressants
- Ezetimibe
- SGLT2 Inhibitors
- Amphotericin B lipid complex (ABLC)
- Sulfamethoxazole
- Raltegravir
- Penicillin
- Mycobacterium avium complex (MAC), disseminated
- Bacillary angiomatosis
- Mycobacterium avium complex (MAC), disseminated
- Gemifloxacin
- Hepatitis C
- Coronavirus COVID-19 (SARS-CoV-2)
- Coronavirus COVID-19 (SARS-CoV-2)
- Sporothrix schenckii